[Cancellation of IVF-ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations]

J Gynecol Obstet Biol Reprod (Paris). 2012 Feb;41(1):41-7. doi: 10.1016/j.jgyn.2011.06.001. Epub 2011 Aug 10.
[Article in French]

Abstract

Introduction: This retrospective study aimed at analyzing IVF-ET management and outcome after cancellation of a first cycle for poor response.

Patients and method: One hundred and forty-two infertile patients were included in this observational study. After an overall analysis on the outcome of the second IVF-ET attempt, a sub-analysis was performed according to the presence or the absence of poor prognostic criteria defined as mentioned: patient age superior to 38 years old, antral follicle count (3-9 mm in diameter) inferior to 10 on cycle day 3 and day 3 serum AMH and FSH levels less than 1 ng/mL and more than 10 IU/mL, respectively. Main outcome measures were the cancellation rates, pregnancy and live birth rates.

Results: When a controlled ovarian stimulation was performed, patients with poor prognosis had higher cancellation rates (37.8% vs. 13.3%, P<0.004) and lower pregnancy and live birth rates (22.2% vs. 35.0%, P<0.05 and 11.1% vs. 26.1%, P<0.05, respectively) as compared to good prognosis women.

Conclusion: The relatively high cancellation rate in patients with poor prognosis raises the question of the use of IVF modified natural cycle in this group.

MeSH terms

  • Adult
  • Age Factors
  • Anti-Mullerian Hormone / blood
  • Anti-Mullerian Hormone / deficiency
  • Female
  • Fertilization in Vitro / methods*
  • Fertilization in Vitro / statistics & numerical data
  • Follicle Stimulating Hormone / blood
  • Humans
  • Live Birth*
  • Menstrual Cycle / physiology*
  • Outcome Assessment, Health Care
  • Ovarian Follicle / anatomy & histology
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Rate*
  • Prognosis
  • Retrospective Studies
  • Treatment Failure
  • Treatment Refusal* / statistics & numerical data
  • Young Adult

Substances

  • Anti-Mullerian Hormone
  • Follicle Stimulating Hormone